查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404823

骶髂关节融合术市场规模、份额和趋势分析报告：2024-2030 年按适应症、治疗类型、最终用户、地区和细分市场进行的预测

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 162 Pages | 商品交期: 2-10个工作天内

价格

骶髂关节融合术市场的成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球骶髂关节融合术市场规模预计将达到 24.9 亿美元。

预计 2024 年至 2030 年复合年增长率为 19.8%。开拓的市场参与者大力投资研发 (R&D) 活动，以开发创新且有效的设备。研发活动的增加预计将推动未来几年的市场成长。此外，由于骨骼病患病率的增加和技术的进步，预计市场将进一步成长。

腰痛、臀部疼痛、鼠蹊部疼痛和下肢疼痛的盛行率不断上升将推动 SI融合术市场的成长。这些慢性且使人衰弱的型态已经变得非常普遍，影响着世界上很大一部分人口。这一趋势为医疗保健系统带来了重大挑战，并刺激了对缓解疼痛和恢復活动能力的创新解决方案的需求。正如医疗保险和医疗补助服务中心 2021 年 12 月报告的那样，下背部、臀部、鼠蹊部和下肢的慢性疼痛占骶髂关节疾病病例的大多数，占病例的 10% 至 26%。与骶髂关节疾病相关的症状的普遍存在凸显了医疗保健面临的重大挑战。

此外，推动市场开拓的因素包括越来越多地使用创新材料和技术来开发改进且更安全的骶髂关节固定係统。例如，2022年10月，专注于微创方法的再生技术公司Aurora Spine宣布取得专利的SiLO TFX MIS获得美国FDA 510(k)许可。此骶髂关节固定係统是针对骶髂关节破坏或退化性骶髂关节炎病例进行骶髂关节固定的微创解决方案。 SiLO TFX 系统由髂骨螺钉、骶骨螺钉、相关器械和定序锥体组成，旨在实现骶骨和髂骨之间骨融合的固定和稳定性。因此，此类技术进步预计将推动市场成长。

2023年，北美以最大的收益占有率主导市场。北美引领全球上肢义肢市场。这一优势得益于先进的医疗基础设施、主要企业的存在以及扩大的报销范围。主要企业正在实施倡议，例如产品临床试验、地理扩张、专利申请、产品发布以及联盟和合作，以扩大市场占有率。

骶髂关节融合术市场报告亮点

  • 有迹象表明，退化性骶髂关节炎细分市场在 2023 年占据最大收益占有率，达到 38.6%。人们对该疾病的认识不断提高，骶髂关节疾病的诊断能力不断提高，是推动这一领域成长的主要因素。
  • 按治疗类型划分，2023 年手术细分市场的收益占有率占据市场主导地位。其优越性是由于微创手术因其切口更小、疼痛和疤痕减少以及恢復时间更快等优点而受到越来越多的偏好。
  • 按最终用途划分，医院细分市场将在 2023 年占据主导地位。医院为患者提供专业的长期护理，并且他们的治疗通常需要报销，这进一步推动了它们的采用。
  • 由于医疗保健基础设施的建立和公司研发投资的增加，北美在 2023 年占据了最大的收益占有率。
  • 由于庞大的患者群、医疗保健设施的发展以及主要企业的投资，预计亚太地区在预测期内将以最快的速度成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章骶髂关节融合市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 骶髂关节融合市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章骶髂关节融合术市场：指标估计与趋势分析

  • 定义和范围
    • 退化性骶髂关节炎
    • 骶骨破坏
    • 创伤
  • 2023年及2030年指示市场占有率
  • 细分仪表板
  • 按适应症分類的全球骶髂关节融合术市场前景
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 退化性骶髂关节炎
    • 骶骨破坏
    • 创伤

第五章骶髂关节融合术市场：治疗类型估计与趋势分析

  • 定义和范围
    • 外科手术
    • 注射
    • 射频消融术
  • 治疗类型市场占有率，2023 年和 2030 年
  • 细分仪表板
  • 按治疗类型分類的全球骶髂关节融合术市场前景
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 外科手术
    • 注射
    • 射频消融术

第六章骶髂关节融合市场：最终用户估计和趋势分析

  • 定义和范围
    • 医院
    • 门诊手术中心
    • 其他的
  • 2023年及2030年最终用户市场占有率
  • 细分仪表板
  • 按最终用户前景分類的全球骶髂关节融合市场
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 医院
    • 门诊手术中心
    • 其他的

第七章骶髂关节融合市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • 创新者
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • SI-BONE, Inc.
    • PainTEQ
    • CornerLoc
    • SIGNUS Medizintechnik GmbH
    • Globus Medical
    • Orthofix Medical, Inc.
    • Life Spine, Inc.
    • Camber Spine Technologies, LLC
    • CoreLink Surgical
    • Xtant Medical
    • Surgalign Spine Technologies, Inc.
    • Medtronic
Product Code: GVR-4-68039-805-9

Sacroiliac Joint Fusion Market Growth & Trends:

The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.

In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.

North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.

Sacroiliac Joint Fusion Market Report Highlights:

  • By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
  • By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
  • By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
  • North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness
  • 3.3. Sacroiliac Joint Fusion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Degenerative sacroiliitis
    • 4.1.2. Sacral disruption
    • 4.1.3. Trauma
  • 4.2. Indication Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Degenerative sacroiliitis
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Sacral disruption
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Trauma
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgery
    • 5.1.2. Injections
    • 5.1.3. RF ablation
  • 5.2. Treatment Type Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgery
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Injections
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. RF ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Ambulatory Surgical Centers
    • 6.1.3. Others
  • 6.2. End user Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Ambulatory surgical centers
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. SI-BONE, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. PainTEQ
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. CornerLoc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SIGNUS Medizintechnik GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Orthofix Medical, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Life Spine, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Camber Spine Technologies, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. CoreLink Surgical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Xtant Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Surgalign Spine Technologies, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Medtronic
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • 1. List of Abbreviation
  • 2. North America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 3. North America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 4. North America sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 5. North America sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 6. U.S. sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 7. U.S. sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 8. U.S. sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 9. Canada sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 10. Canada sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 11. Canada sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 12. Europe sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 13. Europe sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 14. Europe sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 15. Europe sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 16. Germany sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 17. Germany sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 18. Germany sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 19. UK sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 20. UK sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 21. UK sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 22. France sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 23. France sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 24. France sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 25. Italy sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 26. Italy sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 27. Italy sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 28. Spain sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 29. Spain sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 30. Spain sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 31. Denmark sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 32. Denmark sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 33. Denmark sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 34. Sweden sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 35. Sweden sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 36. Sweden sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 37. Norway sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 38. Norway sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 39. Norway sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 40. Asia Pacific sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 41. Asia Pacific sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 42. Asia Pacific sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 43. Asia Pacific sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 44. China sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 45. China sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 46. China sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 47. Japan sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 48. Japan sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 49. Japan sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 50. India sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 51. India sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 52. India sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 53. South Korea sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 54. South Korea sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 55. South Korea sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 56. Australia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 57. Australia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 58. Australia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 59. Thailand sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 60. Thailand sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 61. Thailand sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 62. Latin America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 63. Latin America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 64. Latin America surgical ablation market, by treatment type, 2018 - 2030 (USD Million)
  • 65. Latin America laparoscopic ablation market, by end user, 2018 - 2030 (USD Million)
  • 66. Brazil sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 67. Brazil sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 68. Brazil sacroiliac joint market, by end user, 2018 - 2030 (USD Million)
  • 69. Mexico sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 70. Mexico sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 71. Mexico surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 72. Argentina sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 73. Argentina sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 74. Argentina surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 75. MEA sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 76. MEA sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 77. MEA sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 78. MEA sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 79. South Africa sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 80. South Africa sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 81. South Africa sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 82. Saudi Arabia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 83. Saudi Arabia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 84. Saudi Arabia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 85. UAE sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 86. UAE sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 87. UAE sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 88. Kuwait sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 89. Kuwait sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 90. Kuwait sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)  

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Primary interviews in North America
  • 5. Primary interviews in Europe
  • 6. Primary interviews in APAC
  • 7. Primary interviews in Latin America
  • 8. Primary interviews in MEA
  • 9. Market research approaches
  • 10. Value-chain-based sizing & forecasting
  • 11. QFD modeling for market share assessment
  • 12. Market formulation & validation
  • 13. Sacroiliac joint fusion market: market outlook
  • 14. Sacroiliac joint fusion competitive insights
  • 15. Parent market outlook
  • 16. Related/ancillary market outlook
  • 17. Penetration and growth prospect mapping
  • 18. Industry value chain analysis
  • 19. Sacroiliac joint fusion market driver impact
  • 20 Sacroiliac joint fusion market restraint impact
  • 21. Sacroiliac joint fusion market strategic initiatives analysis
  • 22. Sacroiliac joint fusion market: Indication movement analysis
  • 23. Sacroiliac joint fusion market: Indication outlook and key takeaways
  • 24. Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
  • 25. Sacral disruption market estimates and forecast, 2018 - 2030
  • 26. Trauma market estimates and forecast, 2018 - 2030
  • 27. Sacroiliac joint fusion market: Treatment Type Movement Analysis
  • 28. Sacroiliac joint fusion market: Treatment Type outlook and key takeaways
  • 29. Surgery market estimates and forecast, 2018 - 2030
  • 30. MIS market estimates and forecast,2018 - 2030
  • 31. Open market estimates and forecast, 2018 - 2030
  • 32. Dorsal & Anterior market estimates and forecast,2018 - 2030
  • 33 Lateral market estimates and forecast, 2018 - 2030
  • 34. Implants market estimates and forecast,2018 - 2030
  • 35. Accessories market estimates and forecast,2018 - 2030
  • 36. Injections market estimates and forecast,2018 - 2030
  • 37. Diagnosis market estimates and forecast,2018 - 2030
  • 38 Treatment market estimates and forecast,2018 - 2030
  • 39. RF ablation market estimates and forecast,2018 - 2030
  • 40 Sacroiliac joint fusion market: End User Movement Analysis
  • 41 Sacroiliac joint fusion market: End User outlook and key takeaways
  • 42 Hospitals market estimates and forecast, 2018 - 2030
  • 43 Ambulatory surgical centers market estimates and forecast,2018 - 2030
  • 44 Others market estimates and forecast, 2018 - 2030
  • 45 Global Sacroiliac joint fusion market: Regional movement analysis
  • 46 Global Sacroiliac joint fusion market: Regional outlook and key takeaways
  • 47 Global Sacroiliac joint fusion market share and leading players
  • 48 North America market share and leading players
  • 49 Europe market share and leading players
  • 50 Asia Pacific market share and leading players
  • 51. Latin America market share and leading players
  • 52. Middle East & Africa market share and leading players
  • 53. North America: SWOT
  • 54. Europe SWOT
  • 55. Asia Pacific SWOT
  • 56. Latin America SWOT
  • 57. MEA SWOT
  • 58. North America, by country
  • 59. North America
  • 60. North America market estimates and forecast, 2018 - 2030
  • 61. U.S.
  • 62. U.S. market estimates and forecast, 2018 - 2030
  • 63. Canada
  • 64. Canada market estimates and forecast, 2018 - 2030
  • 65. Europe
  • 66. Europe market estimates and forecast, 2018 - 2030
  • 67. UK
  • 68. UK market estimates and forecast, 2018 - 2030
  • 69. Germany
  • 70. Germany market estimates and forecast, 2018 - 2030
  • 71.. France
  • 72. France market estimates and forecast, 2018 - 2030
  • 73. Italy
  • 74. Italy market estimates and forecast, 2018 - 2030
  • 75. Spain
  • 76. Spain market estimates and forecast, 2018 - 2030
  • 77. Denmark
  • 78. Denmark market estimates and forecast, 2018 - 2030
  • 79. Sweden
  • 80. Sweden market estimates and forecast, 2018 - 2030
  • 81. Norway
  • 82. Norway market estimates and forecast, 2018 - 2030
  • 83. Asia Pacific
  • 84. Asia Pacific market estimates and forecast, 2018 - 2030
  • 85. China
  • 86. China market estimates and forecast, 2018 - 2030
  • 87. Japan
  • 88. Japan market estimates and forecast, 2018 - 2030
  • 89. India
  • 90. India market estimates and forecast, 2018 - 2030
  • 91. Thailand
  • 92. Thailand market estimates and forecast, 2018 - 2030
  • 93. South Korea
  • 94. South Korea market estimates and forecast, 2018 - 2030
  • 95. Australia
  • 96. Australia market estimates and forecast, 2018 - 2030
  • 97. Latin America
  • 98. Latin America market estimates and forecast, 2018 - 2030
  • 99. Brazil
  • 100. Brazil market estimates and forecast, 2018 - 2030
  • 101. Mexico
  • 102. Mexico market estimates and forecast, 2018 - 2030
  • 103. Argentina
  • 104. Argentina market estimates and forecast, 2018 - 2030
  • 105. Middle East and Africa
  • 106. Middle East and Africa market estimates and forecast, 2018 - 2030
  • 107. South Africa
  • 108. South Africa market estimates and forecast, 2018 - 2030
  • 109. Saudi Arabia
  • 110. Saudi Arabia market estimates and forecast, 2018 - 2030
  • 111. UAE
  • 112. UAE market estimates and forecast, 2018 - 2030
  • 113. Kuwait
  • 114. Kuwait market estimates and forecast, 2018 - 2030
  • 115. Market share of key market players- Sacroiliac joint fusion market